↓ Skip to main content

Targeting peripheral blood pro-inflammatory cytotoxic lymphocytes by inhibiting CD137 expression: novel potential treatment for COPD

Overview of attention for article published in BMC Pulmonary Medicine, May 2014
Altmetric Badge

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
28 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Targeting peripheral blood pro-inflammatory cytotoxic lymphocytes by inhibiting CD137 expression: novel potential treatment for COPD
Published in
BMC Pulmonary Medicine, May 2014
DOI 10.1186/1471-2466-14-85
Pubmed ID
Authors

Greg Hodge, Mark Holmes, Hubertus Jersmann, Paul N Reynolds, Sandra Hodge

Abstract

We have shown that chronic obstructive pulmonary disease (COPD) is associated with increased production of pro-inflammatory cytokines and the cytotoxic mediator, granzyme B by peripheral blood steroid resistant CD28nullCD137 + CD8+ T cells and granzyme B by NKT-like and NK cells. We hypothesized that we could target these pro-inflammatory/cytotoxic lymphocytes by inhibiting co-stimulation through CD137.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 28 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 28 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 10 36%
Student > Master 3 11%
Student > Bachelor 2 7%
Student > Ph. D. Student 2 7%
Student > Postgraduate 2 7%
Other 2 7%
Unknown 7 25%
Readers by discipline Count As %
Medicine and Dentistry 6 21%
Biochemistry, Genetics and Molecular Biology 4 14%
Immunology and Microbiology 3 11%
Nursing and Health Professions 2 7%
Agricultural and Biological Sciences 2 7%
Other 4 14%
Unknown 7 25%